XSHE
300249
Market cap827mUSD
Oct 09, Last price
11.98CNY
1D
-0.91%
1Q
-29.15%
Jan 2017
-11.08%
IPO
100.15%
Name
Yimikang Tech Group Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Yimikang Tech.Group Co., Ltd. is a Chinese enterprise primarily engaged in the development, production, and sale of advanced precision air conditioning solutions. Its comprehensive product portfolio includes precision air conditioners, micro-module and smart cabinets, magnetic suspension integrated cold stations, and intelligent control systems. Beyond its core air conditioning offerings, Yimikang also caters to the medical sector, supplying specialized equipment such as SHD modular operating room products designed for prefabricated modular inter-operators, intensive care units (ICUs), sterile supply departments (CSSDs), and laboratories, along with square tower shadowless lamps. Furthermore, the company contributes to environmental protection by manufacturing dust removal, desulfurization, and denitration equipment. Yimikang's diverse clientele spans numerous industries, including government, military, telecommunications, energy, power generation, transportation, healthcare, scientific research, and education. Established in 2002, the company maintains its headquarters in Chengdu, China. It initially operated as Sichuan Yimikang Environmental Tech. Co., Ltd. before officially adopting its current name, Yimikang Tech.Group Co., Ltd., in February 2018.
Key people
Wan Zhang
Chairman of the Board · since 2025
Jing Ye
Secretary of the Board · since 2022
Mingjie Rui
Director · since 2021
Jingjing Sun
Deputy General Manager, Director · since 2025
Independent Director · since 2022
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||